PRPeter ReissMD, PhDVideoHIVViral Hepatitis and Liver DiseaseTuberculosisRSVAPACC 2023Improving the Lives of People Living With and at Risk of HIV as Physician-Scientist, Visionary Leader, and Activist, Peter Reiss, MD, PhDView Video
IAIskandar AzwaMBChB, MRCP, Dip GUM, Dip HIVVideoHIVViral Hepatitis and Liver DiseaseTuberculosisRSVAPACC 2023The Role of Nucleosides in Second-Line HIV Treatment, Iskandar Azwa, MBChB, MRCP, DIP GUM, DIP HIVView Video
JHJennifer HoyMBBS, AM, FRACP, FAHMSVideoHIVViral Hepatitis and Liver DiseaseTuberculosisRSVAPACC 2023Considerations When Switching ART in People Living With HIV Who Are Virologically Suppressed, Jennifer Hoy, AM, FRACP, FAHMSJennifer Hoy, AM, FRACP, FAHMSView Video
VideoHIVViral Hepatitis and Liver DiseaseTuberculosisRSVAPACC 2023The Role of a Novel TmPV1 Mycovirus on Talaromyces Marneffei Virulence and Its Impact on Human Talaromycosis Outcomes, Matt BurkeView Video
VideoHIVViral Hepatitis and Liver DiseaseTuberculosisRSVAPACC 2023Incidence and Factors Associated With Hepatitis B Surface Antigen Seroclearance in HIV/HBV Coinfected Patients During Combination Antiretroviral Therapy, Yaozu HeView Video
VideoHIVViral Hepatitis and Liver DiseaseTuberculosisRSVAPACC 2023In Vitro Synergy of Amphotericin B and Flucytosine Against Talaromyces Marneffei – Implications for Novel Treatment Approaches Against a Leading Aids-Associated Mycosis in Southeast Asia, Shawin VitsupakornView Video
VideoHIVViral Hepatitis and Liver DiseaseTuberculosisRSVAPACC 2023The Community-Led Model Improves HBV/HCV testing Among Men Who Have Sex With Men in China, Ye ZhangView Video
AAAnchalee AvihingsanonMD, PhDVideoHIVViral Hepatitis and Liver DiseaseTuberculosisRSVAPACC 2023Clinical Care Beyond Viral Suppression, Anchalee Avihingsanon, MD, PhDView Video
TTCThomas Tao CaiVideoHIVViral Hepatitis and Liver DiseaseTuberculosisRSVAPACC 2023Community Perspective, Thomas Tao CaiView Video
PRPeter ReissMD, PhDVideoHIVViral Hepatitis and Liver DiseaseTuberculosisRSVAPACC 2023Perspectives on HIV and Aging, Peter Reiss, MD, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseTuberculosisRSVAPACC 2023Strength in Diversity: HIV Pre-exposure Prophylaxis (PrEP) Product Interest and Preferences Among Transgender Women in 11 Countries in Asia, Nachale BoonyapisomparnView Video
VideoHIVViral Hepatitis and Liver DiseaseTuberculosisRSVAPACC 2023Drug-Drug Interaction Between Emtricitabine/Tenofovir Alafenamide (FTC/TAF)-Based PrEP and Feminizing Hormones in Transgender Women: Peripheral Blood Mononuclear Cells and Urine Analysis From the iFACT3 Study, Akarin HiransuthikulView Video
